Literature DB >> 35023895

Dense deposit disease in an adolescent male mimicking acute post-streptococcal glomerulonephritis.

E Siomou1, G Liapis2, A Zisi1, D Csuka3, Z Prohászka3.   

Abstract

BACKGROUND: Dense deposit disease (DDD), a subtype of complement factor 3 glomerulopathy (C3G), is a rare entity associated with dysregulation of the alternative complement pathway. It usually affects children, with a 50% likelihood of progression to end-stage renal disease within ten years of diagnosis. Description of the case: We report the case of an adolescent male with acute nephritic syndrome and nephrotic range proteinuria, initially diagnosed as acute post-streptococcal glomerulonephritis (APSGN). Despite his spontaneous improvement, renal biopsy, performed due to a persistently low C3 level for over 18 weeks, confirmed the diagnosis of DDD. Complement and genetic studies showed high levels of C3-nephritic factor and risk polymorphisms for developing the disease. He was treated with prednisolone and mycophenolate mofetil (MMF). At the last follow-up, 15 months from onset, the serum creatinine level and 24h-hour total protein excretion were normal.
CONCLUSION: C3G (including the DDD subtype) should be suspected in apparent APSGN with atypical clinical features at presentation/follow-up, even in the case of spontaneous improvement. Timely and accurate diagnosis, based on histopathological, complement, and genetic studies, is important to initiate the appropriate treatment aimed at preventing or slowing the disease progression. HIPPOKRATIA 2020, 24(4): 191-193. Copyright 2020, Hippokratio General Hospital of Thessaloniki.

Entities:  

Keywords:  Complement factor 3 glomerulopathy; adolescent; child; dense deposit disease; post-streptococcal glomerulonephritis

Year:  2020        PMID: 35023895      PMCID: PMC8747577     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  12 in total

1.  Allelic variants of complement genes associated with dense deposit disease.

Authors:  Maria Asuncion Abrera-Abeleda; Carla Nishimura; Kathy Frees; Michael Jones; Tara Maga; Louis M Katz; Yuzhou Zhang; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

Review 2.  C3 glomerulopathy - understanding a rare complement-driven renal disease.

Authors:  Richard J H Smith; Gerald B Appel; Anna M Blom; H Terence Cook; Vivette D D'Agati; Fadi Fakhouri; Véronique Fremeaux-Bacchi; Mihály Józsi; David Kavanagh; John D Lambris; Marina Noris; Matthew C Pickering; Giuseppe Remuzzi; Santiago Rodriguez de Córdoba; Sanjeev Sethi; Johan Van der Vlag; Peter F Zipfel; Carla M Nester
Journal:  Nat Rev Nephrol       Date:  2019-03       Impact factor: 28.314

3.  Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.

Authors:  Aude Servais; Laure-Hélène Noël; Lubka T Roumenina; Moglie Le Quintrec; Stephanie Ngo; Marie-Agnès Dragon-Durey; Marie-Alice Macher; Julien Zuber; Alexandre Karras; François Provot; Bruno Moulin; Jean-Pierre Grünfeld; Patrick Niaudet; Philippe Lesavre; Véronique Frémeaux-Bacchi
Journal:  Kidney Int       Date:  2012-03-28       Impact factor: 10.612

4.  Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation.

Authors:  Rubén Martínez-Barricarte; Meike Heurich; Francisco Valdes-Cañedo; Eduardo Vazquez-Martul; Eva Torreira; Tamara Montes; Agustín Tortajada; Sheila Pinto; Margarita Lopez-Trascasa; B Paul Morgan; Oscar Llorca; Claire L Harris; Santiago Rodríguez de Córdoba
Journal:  J Clin Invest       Date:  2010-09-13       Impact factor: 14.808

Review 5.  Postinfectious glomerulonephritis.

Authors:  Neeraja Kambham
Journal:  Adv Anat Pathol       Date:  2012-09       Impact factor: 3.875

6.  A new screening test for C3 nephritis factor based on a stable cell bound convertase on sheep erythrocytes.

Authors:  U Rother
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

7.  Acute post-streptococcal glomerulonephritis in children of French Polynesia: a 3-year retrospective study.

Authors:  Odile Becquet; Jérôme Pasche; Hélène Gatti; Claude Chenel; Michel Abély; Patrice Morville; Christine Pietrement
Journal:  Pediatr Nephrol       Date:  2009-10-30       Impact factor: 3.714

8.  Clinicopathological features of C3 glomerulopathy in children: a single-center experience.

Authors:  Keri A Drake; Natalie Ellington; Jyothsna Gattineni; Jose R Torrealba; Allen R Hendricks
Journal:  Pediatr Nephrol       Date:  2019-10-30       Impact factor: 3.714

9.  Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Authors:  Timothy H J Goodship; H Terence Cook; Fadi Fakhouri; Fernando C Fervenza; Véronique Frémeaux-Bacchi; David Kavanagh; Carla M Nester; Marina Noris; Matthew C Pickering; Santiago Rodríguez de Córdoba; Lubka T Roumenina; Sanjeev Sethi; Richard J H Smith
Journal:  Kidney Int       Date:  2016-12-16       Impact factor: 10.612

Review 10.  New approaches to the treatment of dense deposit disease.

Authors:  Richard J H Smith; Jessy Alexander; Paul N Barlow; Marina Botto; Thomas L Cassavant; H Terence Cook; Santiago Rodriguez de Córdoba; Gregory S Hageman; T Sakari Jokiranta; William J Kimberling; John D Lambris; Lynne D Lanning; Vicki Levidiotis; Christoph Licht; Hans U Lutz; Seppo Meri; Matthew C Pickering; Richard J Quigg; Angelique L Rops; David J Salant; Sanjeev Sethi; Joshua M Thurman; Hope F Tully; Sean P Tully; Johan van der Vlag; Patrick D Walker; Reinhard Würzner; Peter F Zipfel
Journal:  J Am Soc Nephrol       Date:  2007-08-05       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.